share_log

Assure | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Assure | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Assure | 425：募资说明/企业合并公告
美股sec公告 ·  05/08 12:50
Moomoo AI 已提取核心信息
On May 6, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company emphasized the importance of each vote, noting that more than 95% of votes received to date were in favor of the proposal, but a majority of outstanding shares is required for approval. Assure's CEO, John Farlinger, highlighted the necessity for stockholders with smaller positions to vote, as larger stockholders alone cannot ensure the proposal's passage. The increase in authorized shares is critical for the company's capital needs, and failure...Show More
On May 6, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company emphasized the importance of each vote, noting that more than 95% of votes received to date were in favor of the proposal, but a majority of outstanding shares is required for approval. Assure's CEO, John Farlinger, highlighted the necessity for stockholders with smaller positions to vote, as larger stockholders alone cannot ensure the proposal's passage. The increase in authorized shares is critical for the company's capital needs, and failure to approve the proposal could delay the company's plans. Assure has filed a definitive proxy statement with the SEC and has provided information on how stockholders can vote. The company also mentioned an ongoing proposed transaction with Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.
2024年5月6日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp. 发布了一份新闻稿，敦促其股东对将授权普通股数量从900万股增加到2.5亿股的提议投赞成票。股东特别会议定于2024年5月14日举行。该公司强调了每一次投票的重要性，指出迄今为止收到的超过95％的选票支持该提案，但需要大多数已发行股票才能获得批准。Assure的首席执行官约翰·法林格强调了让持仓较小的股东进行投票的必要性，因为光靠较大的股东无法确保该提案获得通过。法定股票的增加对公司的资本需求至关重要，不批准该提案可能会推迟公司的计划。Assure已向美国证券交易委员会提交了最终的委托书，并提供了有关股东如何投票的信息。该公司还提到了与Danam Health Inc. 正在进行的拟议交易，该交易的材料已向美国证券交易委员会提交，包括一份包含招股说明书和委托书的注册声明。
2024年5月6日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp. 发布了一份新闻稿，敦促其股东对将授权普通股数量从900万股增加到2.5亿股的提议投赞成票。股东特别会议定于2024年5月14日举行。该公司强调了每一次投票的重要性，指出迄今为止收到的超过95％的选票支持该提案，但需要大多数已发行股票才能获得批准。Assure的首席执行官约翰·法林格强调了让持仓较小的股东进行投票的必要性，因为光靠较大的股东无法确保该提案获得通过。法定股票的增加对公司的资本需求至关重要，不批准该提案可能会推迟公司的计划。Assure已向美国证券交易委员会提交了最终的委托书，并提供了有关股东如何投票的信息。该公司还提到了与Danam Health Inc. 正在进行的拟议交易，该交易的材料已向美国证券交易委员会提交，包括一份包含招股说明书和委托书的注册声明。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息